Form 4 for PPCB Propanc Biopharma, Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-17 · accession 0001493152-21-020759 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-20 | 2021-08-17 | PPCB | Kenyon Julian Norman | CSO, Dir | A - Grant | $0.00 | +3.42M | 3.42M | +68,400,000% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2021-08-17 | A | A | 3,420,000 | $0.00 | 3,420,005 | D | — | — |